Cabaletta Bio Earnings Estimate
| CABA Stock | USD 2.51 0.18 7.73% |
Cabaletta | Build AI portfolio with Cabaletta Stock |
Cabaletta Bio Earnings Estimation Breakdown
The calculation of Cabaletta Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cabaletta Bio is estimated to be -0.4193 with the future projection ranging from a low of -0.4775 to a high of -0.2925. Please be aware that this consensus of annual earnings estimates for Cabaletta Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.48 Lowest | Expected EPS | -0.29 Highest |
Cabaletta Bio Earnings Projection Consensus
Suppose the current estimates of Cabaletta Bio's value are higher than the current market price of the Cabaletta Bio stock. In this case, investors may conclude that Cabaletta Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cabaletta Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 10 | 81.88% | 0.0 | -0.4193 | -2.4 |
Cabaletta Bio Earnings per Share Projection vs Actual
Actual Earning per Share of Cabaletta Bio refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Cabaletta Bio predict the company's earnings will be in the future. The higher the earnings per share of Cabaletta Bio, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Cabaletta Bio Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Cabaletta Bio, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Cabaletta Bio should always be considered in relation to other companies to make a more educated investment decision.Cabaletta Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Cabaletta Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-10 | 2025-09-30 | -0.4721 | -0.44 | 0.0321 | 6 | ||
2025-08-07 | 2025-06-30 | -0.6499 | -0.73 | -0.0801 | 12 | ||
2025-05-13 | 2025-03-31 | -0.6611 | -0.65 | 0.0111 | 1 | ||
2025-03-19 | 2024-12-31 | -0.6264 | -0.65 | -0.0236 | 3 | ||
2024-11-07 | 2024-09-30 | -0.6 | -0.62 | -0.02 | 3 | ||
2024-08-08 | 2024-06-30 | -0.55 | -0.56 | -0.01 | 1 | ||
2024-05-15 | 2024-03-31 | -0.48 | -0.51 | -0.03 | 6 | ||
2024-03-21 | 2023-12-31 | -0.39 | -0.46 | -0.07 | 17 | ||
2023-11-09 | 2023-09-30 | -0.4 | -0.37 | 0.03 | 7 | ||
2023-08-10 | 2023-06-30 | -0.44 | -0.37 | 0.07 | 15 | ||
2023-05-11 | 2023-03-31 | -0.48 | -0.45 | 0.03 | 6 | ||
2023-03-16 | 2022-12-31 | -0.45 | -0.52 | -0.07 | 15 | ||
2022-11-10 | 2022-09-30 | -0.48 | -0.39 | 0.09 | 18 | ||
2022-08-11 | 2022-06-30 | -0.5 | -0.45 | 0.05 | 10 | ||
2022-05-12 | 2022-03-31 | -0.6 | -0.45 | 0.15 | 25 | ||
2022-03-17 | 2021-12-31 | -0.6 | -0.49 | 0.11 | 18 | ||
2021-11-01 | 2021-09-30 | -0.5 | -0.45 | 0.05 | 10 | ||
2021-08-05 | 2021-06-30 | -0.5 | -0.45 | 0.05 | 10 | ||
2021-05-03 | 2021-03-31 | -0.46 | -0.41 | 0.05 | 10 | ||
2021-03-16 | 2020-12-31 | -0.36 | -0.4 | -0.04 | 11 | ||
2020-11-10 | 2020-09-30 | -0.44 | -0.36 | 0.08 | 18 | ||
2020-08-06 | 2020-06-30 | -0.39 | -0.35 | 0.04 | 10 | ||
2020-05-12 | 2020-03-31 | -0.23 | -0.33 | -0.1 | 43 | ||
2020-03-30 | 2019-12-31 | -0.65 | -0.33 | 0.32 | 49 | ||
2019-12-05 | 2019-09-30 | -1.33 | -2.17 | -0.84 | 63 | ||
2019-08-28 | 2019-06-30 | -3.74 | -3.74 | 0.0 | 0 |
About Cabaletta Bio Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Cabaletta Bio earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Cabaletta Bio estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Cabaletta Bio fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -314.2 M | -298.5 M | |
| Retained Earnings Total Equity | -149 M | -156.5 M | |
| Earnings Yield | (1.19) | (1.13) | |
| Price Earnings Ratio | (0.87) | (0.92) | |
| Price Earnings To Growth Ratio | (0.03) | (0.03) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. Projected growth potential of Cabaletta fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Cabaletta Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Cabaletta Bio's market price often diverges from its book value, the accounting figure shown on Cabaletta's balance sheet. Smart investors calculate Cabaletta Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Cabaletta Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Cabaletta Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Cabaletta Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.